Alphamab starts phase I clinical trial in Australia

Australia |  News | 0 Comment | 11 Oct, 2018

Alphamab Oncology has announced that its proprietary humanized PD-L1 - CTLA-4 bispecific antibody program, the first of its class, has recently started phase I clinical trial in Australia. ...Read more

MGC Pharma receives TGA approval to market epilepsy drug in Australia

Australia |  News | 0 Comment | 11 Oct, 2018

Australia's MGC Pharmaceuticals is pleased to announce the receipt of formal authorisation for the availability of its product CannEpil for supply in Australia through specialist prescriber...Read more

One-third unplanned pregnancies aborted in Australia, says a survey

Australia |  News | 0 Comment | 08 Oct, 2018

One in three unwanted pregnancies end in abortion, if recent research undertaken in Australia is any indication. The research, published in the Medical Journal of Australia, found that one...Read more

RMIT, Atmo sign licence agreement for gut sensors

Australia |  News | 1 Comment | 03 Oct, 2018

RMIT University in Australia has signed a commercial licence agreement with start-up Atmo Biosciences for ingestible sensors developed to measure gases in the gut in order to diagnose gut-r...Read more

Invion spin-off selects leading CRO for nadolol development

Australia |  News | 0 Comment | 27 Sep, 2018

Singapore - Chronic Airway Therapeutics (CAT), a proposed spin-off from Invion Limited, has selected leading Chinese contract research organisation R&G Pharma Studies to support the dev...Read more

Virtus appoints new non-executive director

Australia |  News | 0 Comment | 27 Sep, 2018

Singapore – Virtus Health announces the appointment of Shane Solomon to its Board as a Non-Executive Director. Solomon is a highly experienced healthcare professional having worked in...Read more

Sun Pharma announces Australian TGA approval of ILUMYA

Australia |  News | 0 Comment | 25 Sep, 2018

India's Sun Pharmaceutical recently announced that Sun Pharma has received the Australian Therapeutic Goods Administration (TGA) approval for its speciality product, ILUMYA (tildrakizumab) ...Read more

Minomic announces demerger of Glytherix

Australia |  News | 0 Comment | 25 Sep, 2018

Minomic International Ltd has announced that it received strong shareholder approval to approve the demerger of its therapeutic subsidiary, GlyTherix Ltd, at a recent extraordinary gen...Read more

Immutep collaborates with Merck, Pfizer for Efti

Australia |  News | 0 Comment | 25 Sep, 2018

Immutep Limited has announced that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc., to evaluate the combination o...Read more

Daily intake of Aspirin has little effect on cardiovascular disease, says a study

Australia |  News | 0 Comment | 17 Sep, 2018

Three groundbreaking papers published in New England Journal of Medicine, led by a team of Monash University researchers in Melbourne, reveal the results from a seven-year study of the bene...Read more

Invion to spinout respiratory assets, advance clinical development in China

Australia |  News | 0 Comment | 12 Sep, 2018

Australia-based Invion recently announced plans to  spin off its two assets aimed at treating chronic airway disease into a new public unlisted company, which will develop the products...Read more

Cancer Australia releases new diagnostic data

Australia |  News | 0 Comment | 11 Sep, 2018

For the first time, national data on childhood cancer stage at diagnosis has been released, showing that a high proportion of the most common childhood cancers are diagnosed at a limited st...Read more

Photosoft granted patent protection in Australia

Australia |  News | 0 Comment | 10 Sep, 2018

Singapore - ASX-listed life- sciences company, Invion Limited announces the grant in Australia of the patent for chlorin e4 sodium, a new generation photodynamic therapy over which Invion h...Read more

Centre marks new era in Israel-Australia research

Australia |  News | 0 Comment | 06 Sep, 2018

Singapore - A new Israel-Australia research centre involving a major collaboration with Monash University will be officially launched in Tel Aviv, Israel. The Sagol Center f...Read more

Vertex announces reimbursement agreement in Australia for ORKAMBI

Australia |  News | 0 Comment | 05 Sep, 2018

Vertex Pharmaceuticals announced the finalization of an agreement with the Australian Government that allows for reimbursement of ORKAMBI (lumacaftor/ivacaftor) for people ages six and...Read more

Cadrock gets $5M seed funding for heart therapy

Australia |  News | 0 Comment | 04 Sep, 2018

Cadrock Pty Ltd, which owns an investigational prevention and treatment therapy for coronary artery disease (CAD), has secured a $5 million seed investment from a Chinese investor to fund c...Read more

Australian scientists detect cancer with gold plated nanoparticles

Australia |  News | 0 Comment | 30 Aug, 2018

Researchers from the University of New South Wales (UNSW Sydney) in Australia have used gold-plated nanoparticles to detect low microRNA (miRNA) levels in blood samples. Impaired miRNA act...Read more

BGI, Xing Tech to advance diagnostic technologies

Australia |  News | 0 Comment | 27 Aug, 2018

Beijing Genomics Institute (BGI) has signed a Memorandum of Understanding (MoU) with Australian firm Xing Technology aimed at the translation of diagnostic technologies. The partners will ...Read more